Bayer Corp. said net income for the first quarter slipped by 8.4 percent from a year ago, mainly due to special costs related to its acquisition of the over-the-counter business of drug giant Merck & Co.

The German-based chemicals and pharmaceuticals company said sales jumped by 15 percent to 12.1 billion euros ($13.5 billion) from 10.6 billion euros in the first quarter of 2014.

Net income was 1.3 billion euros, down from 1.4 billion euros in the first quarter of 2014.

Bayer, which operates the North American headquarters for its material science segment in Robinson, said it is on schedule to float that unit as a separate business by next year.

Joyce Gannon: jgannon@post-gazette.com or 412-263-1580.